西南国防医药2018，Vol.28Issue(5)：430-432,3.DOI:10.3969/j.issn.1004-0188.2018.05.012
两种药物在表浅性膀胱癌术后灌注的疗效及经济性分析
Efficacy and cost-effectiveness of two drugs in postoperative perfusion for superficial bladder cancer
贾军琪 1靳永胜 1张培波 1汪峰 1李义 1郭巍1
作者信息
- 1. 716000 陕西延安,延安大学附属医院泌尿外科
- 折叠
摘要
Abstract
Objective To explore the efficacy and cost-effectiveness of hydroxycamptothecin and pirarubicin in postoperative perfusion for superficial bladder cancer.Methods The clinical data of 123 patients with superficial bladder cancer treated with transurethral bladder cancer resection were retrospectively analyzed.These patients were divided into a hydroxycamptothecin group and a pirarubicin group according to different chemotherapy drugs.The two groups were treated with transurethral bladder cancer resection.One week after the operation,intravesical infusion chemotherapy was carried out.The efficiency,adverse reactions and cost-effectiveness ratio one year after the operation between the two groups were compared.Results The curative effects and incidences of adverse reactions showed no statistical difference between the two groups (P ＞ 0.05),but the cost-effectiveness ratio in the hydroxycamptothecin group was much lower than that in the pirarubicin group (P ＜ 0.05).Conclusion The efficacy of hydroxycamptothecin in the postoperative infusion chemotherapy for superficial bladder cancer was equivalent to that of pirarubicin,but hydroxycamptothecin is more cost-effective.关键词
羟基喜树碱/吡柔比星/表浅性膀胱癌/疗效/成本-效果比Key words
hydroxycamptothecin/pirarubicin/superficial bladder cancer/efficacy/cost-effective ratio分类
医药卫生引用本文复制引用
贾军琪,靳永胜,张培波,汪峰,李义,郭巍..两种药物在表浅性膀胱癌术后灌注的疗效及经济性分析[J].西南国防医药,2018,28(5):430-432,3.
